Traffic Lights
Brolucizumab (Beovu)
Status:
Red
Decision Date:
March 2021
Comments
RED:
NICE TA672
: for treating wet age-related macular degeneration.
NICE TA820
:
for treating diabetic macular oedema. (Decision date - September 2022)
search again